Feb 3 • 17:17 UTC 🇩🇰 Denmark Politiken

Dismal prediction: If Novo is correct, 2026 could be the worst year of this millennium

Novo Nordisk reported a revenue of just over 309 billion kroner in 2025 with a six percent growth, despite a slowdown in the sales growth of weight-loss drugs in the fourth quarter, although sales of the popular Wegovy still exceeded analysts' expectations.

📡 Similar Coverage